A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
Public ClinicalTrials.gov record NCT02656875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with TRV130 by IV bolus, PCA (patient-controlled analgesia) administration, or both, as determined by the investigator, for a duration not to exceed 14 days.
Study identification
- NCT ID
- NCT02656875
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 768 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- May 2017 (Actual)
- Completion
- Aug 2017 (Actual)
- Last update posted
- Sep 24, 2020
2015 – 2017
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Recruiting | Mobile | Alabama | 36608 | — |
| Recruiting | Pasadena | California | 91105 | — |
| Recruiting | Miami | Florida | 33155 | — |
| Recruiting | Shreveport | Louisiana | 71101 | — |
| Recruiting | Jackson | Mississippi | 39202 | — |
| Not listed | Staten Island | New York | 10305 | — |
| Recruiting | State College | Pennsylvania | 16801 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77027 | — |
| Recruiting | Murray | Utah | 84123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02656875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2020 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02656875 live on ClinicalTrials.gov.